RB1 and benign prostatic hyperplasia: Although 6SL did not inhibit prostatic cell growth, pRB/E2F1–AR protein expression was significantly inhibited, supporting the non-cytotoxic but specific inhibitory effects of 6SL on the pathological or abnormal expression of BPH-related genes.